Dr. Andrew Sylvester provided Grand Rounds this morning. He discussed the disorder known as Neuromyelitis Optica or Devic’s Disease. This condition is similar to Multiple Sclerosis in many regards and was once thought to be a variation of MS. Over the last few years, however, the syndrome has been investigated extensively and is a distinct disorder, with a different pathophysiology from MS.
Many of you have requested information on the published papers Dr. Deneb Bates referred to during her presentation on The Healing Environment. We are pleased to post the abstracts and links to where those papers can be obtained.
Influence of Dietary Components on Regulatory T Cells
Commensal Microbiota and Myelin Autoantigen Cooperate to Trigger Autoimmune...
Dr. Deneb Bates spoke at Grand Rounds today, providing an overview of naturopathic medicine and specifically how it relates to the pathology of Multiple Sclerosis. The main points of the discussion related to environmental factors associated with MS. The role of stress and how it relates to the integrity of the pituitary-hypothalamic-adrenal axis, which is essential for normal steroid production in the body and the stress response, was discussed in depth.
The IMSMP would like to thank everyone who attended the 2013 Tisch MS Research Center Patient Education Symposium. This was the largest patient symposium ever held with almost 1,000 patients, family members and caregivers. We appreciate the time, effort and energy everyone took to travel from far and near making this such a truly outstanding event!
Dr. Violaine Harris's and Dr.
The IMSMP has a new physical therapist. Please help us welcome Dr. Elizabeth Woods, PT, DPT, MSCS to our practice. For Dr. Woods complete bio, please go to our staff page:
Dr. Brenda Banwell spoke at Grand Rounds this week on the subject of pediatric multiple sclerosis. Dr. Banwell is the chief of pediatric neurology at Children’s Hospital of Philadelphia as well as the director of the pediatric multiple sclerosis clinic at the Hospital for Sick Children in Toronto. Pediatric MS is far less common than adult MS and behaves somewhat differently in several ways.
Today the European Medicines Agency (EMA) has approved the drug Alemtuzumab, trade name Lemtrada, and formerly known as Campath, for the treatment of multiple sclerosis. Alemtuzumab’s manufacturer is awaiting a decision from the FDA regarding approval in the United States. Alemtuzumab is a monoclonal antibody that has also been used in the treatment of various immune system cancers, like lymphoma and leukemia. Alemtuzumab appears to a powerful drug in the treatment of relapsing-remitting MS...
Dr. Jonathan Vapnek provided Grand Rounds this week. Dr. Vapnek is a urologist with a focus on the urologic complications of neurologic diseases. He practices on the upper east side of Manhattan and at Mt. Sinai Hospital. During the lecture, he reviewed the approach and management of urologic symptoms in neurological conditions, and provided an interesting perspective on novel treatments and procedures.
The NYC Department of Transportation has changed the signage to the east of 521 West 57th Street to read “No Parking 8AM – 8PM including Sunday, Patient Drop-off and Pick-up.” This means that press and other cars that currently park in that spot will no longer be authorized, and stopping will only be allowed for drop-off and pick-up of our patients.